Insider information
20. August 2021 - 0:00 (CEST)
Epigenomics AG: Reduction of principal amount of planned mandatory convertible bond to up to EUR 16.5 million and of conversion price to EUR 1.10 per share
Read more17. August 2021 - 0:00 (CEST)
Epigenomics AG: Execution of a Biobank Sale Agreement and Update of Guidance
Read more11. June 2021 - 0:00 (CEST)